NeoGenomics' PanTracer™ LBx test has received coverage from the Centers for Medicare & Medicaid Services’ Molecular ...

NeoGenomics Inc. (NASDAQ:NEO) is one of the most buzzing stocks to buy with the highest upside potential. On February 25, ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and ...

In this article, we will discuss the 11 Most Buzzing Stocks to Buy with the Highest Upside Potential. On March 4, Henry McVey, Head of Global Macro & Asset Allocation at KKR and CIO of the firm’s ...

Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats ...

When a person with cancer finds out they carry an inherited genetic variant that puts them at higher risk of cancer, the ...

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ...

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most ...

A $4.7 million collaboration led by the National Cancer Centre Singapore will develop a clinical-grade test using AI and ...

In this episode of The OncoloGIST, breast cancer oncologist and clinical researcher Dr Paolo Tarantino of Dana-Farber Cancer ...